3515. Adulteration and misbranding of Hemotene tablets.   U. S. v. 148 Bottles,
etc.    (F. D. C. No. 31181.    Sample No. 16763-L.)
LIBEL FILED: June 7, 1951, Southern District of California; amended libel
filed June 28, 1951.
Midwest Chemical Development Corp., from Cleveland, Ohio.
PRODUCT: Hemotene tablets. 148 bottles, each containing 270 tablets, and 443
bottles, each containing 90 tablets, at Los Angeles, Calif. Analysis showed
that the article contained substantially less than the stated amount of
vitamins C and D.
LABEL, IN PART:    (Bottle) "Hemotene   With Organic Iron and B-12."
NATURE OF CHARGE: Adulteration, Section 501 (c), the strength of the article
differed from that which it purported and was represented to possess, namely,
120 milligrams of vitamin C and 2,000 U. S. P. units of vitamin D.
Misbranding, Section 502 (a), the label statements "Six Hemotene Tablets
provide: * * * Vitamin C 120 milligrams Vitamin D 2000 U. S. P.
Units * * * Six tablets supply * * * M. D. R. * * * 4 times
that of Vitamin C and 5 times that of Vitamin D" were false and misleading
as applied to an article containing less than the stated amounts of vitamins C
and D. Further misbranding, Section 502 (a), the label designation "Hemo-
tene With Organic Iron and B-12" was false and misleading. The label
designation represented and suggested that the article, because of its vita-
min Bu content, was effective in the treatment of nutritional anemia due to
iron deficiency, whereas the article, because of its vitamin Bi2 content, was
not effective in the treatment of such condition.
DISPOSITION :   July 27, 1951.   Default decree of condemnation and destruction.